US EditionPublished • loading... • Updated
Czechs greenlight magic mushroom use from 2026
Psilocybin will be prescribed for severe depression and life-threatening mental conditions when other treatments fail, following a penal code amendment legalizing its use earlier this year.
- On Wednesday, the outgoing Czech government approved medical use of psilocybin, the active ingredient in magic mushrooms, from 2026 at its last meeting.
- In May, lawmakers in the Czech Republic legalised psilocybin via a penal-code amendment that also eased marijuana rules, amid renewed scientific interest in psychedelic substances including psilocybin, LSD and MDMA.
- Psychiatrists and psychotherapists may administer psilocybin under narrow conditions, limited to cancer-related depression, clinically serious depression without psychotic symptoms, or worsened mental conditions threatening life when registered treatments fail.
- Health Minister Vlastimil Valek hailed the decision as benefiting `the Czech health system, the expert public and patients`, and the approval comes days before Andrej Babis is sworn in next Monday.
- Amid similar international moves, Germany allowed two clinics a `compassionate use programme` in July, while New Zealand approved psilocybin for depression treatment this year.
Insights by Ground AI
11 Articles
11 Articles
Coverage Details
Total News Sources11
Leaning Left1Leaning Right0Center3Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
L 25%
C 75%
Factuality
To view factuality data please Upgrade to Premium
